From: Multiple functions of hypoxia-regulated miR-210 in cancer
First author | Publication year | Types of cancer | Types of sample | Negative controls | Sensitivity | Specificity |
---|---|---|---|---|---|---|
Wang [81] | 2009 | Pancreatic cancer | plasma | Healthy controls | 53% | 78% |
Xing [86] | 2010 | Squamous cell LC | sputum | Healthy controls | 58% | 79% |
Shen [94] | 2011 | Lung cancer | plasma | Benign SPNs | 56% | 73% |
Tan [95] | 2011 | Squamous cell LC | tissue | Normal lung tissue | Not provided | Not provided |
Ren [96] | 2012 | Pancreatic cancer | stool | Healthy controls | 85% | 67% |
Li [97] | 2013 | NSCLC | sputum | Healthy controls | Not provided | Not provided |
Li [98] | 2013 | NSCLC | serum | Healthy controls | 79% | 74% |
Zhao [99] | 2013 | Renal cancer | serum | Healthy controls | 81% | 79% |
Iwamoto [100] | 2014 | Renal cancer | serum | Healthy controls | 65% | 83% |